Key facts
- Bala Enzyme’s last known valuation is $6.8M (Dec 2025).
- It has raised $1.9M across 2 recorded rounds; the latest was Seed Round ($921K) in Nov 2025.
- Notable investors include Franki Cohen 2024 Legacy Trust, Kenneth Sadowsky, SKU.
- Bala Enzyme has filed 2 Form Ds with the SEC since 2022, most recently Dec 2025 ($921K sold to 6 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Bala Enzyme
Funding rounds
2 roundsAbout Bala Enzyme
Producer of sports drinks intended to provide hydration. The company offers nutrition powder mix, keto-friendly, gluten-free beverages that is made from a patent-pending blend of turmeric and bromelain from pineapple, papain and papaya, enabling individuals to consume body wellness drinks for effective muscle recovery and digestion.
- Sector
- Consumer Products and Services (B2C)
- HQ
- Seal Beach, CA, United States
- Founded
- 2018
- Employees
- 5
- Website
- balaenzyme.com/
- Ownership
- Privately Held (backing)
Bala Enzyme doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Bala Enzyme shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Bala Enzyme in its N-PORT filings yet. We sweep new filings monthly.